Page 50 - Read Online
P. 50

Page 12 of 25                   Han et al. Cancer Drug Resist 2024;7:16  https://dx.doi.org/10.20517/cdr.2024.01














































































                Figure 3. (A) Relationship between mRNA expression levels of AKT1 and clinicopathological features in patients with glioma. Significant
                                                               ****
                differences in the expression of (WHO II, WHO III, and WHO IV) (  P < 0.0001 vs. control group). Significant differences among
                                                ****
                different states of IDH (wild type, mutant type) (  P < 0.0001 vs. control group). Significant differences among different age status (</≥
   45   46   47   48   49   50   51   52   53   54   55